The role of MTDH/AEG-1 in the progression of cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 4795-4807

  Shi, Xue ^a,c   Wang, Xin ^a,b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Cancer progression; Carcinogenesis; MTDH AEG 1; Signaling pathway; Target therapy

Indexed keywords

BETA CATENIN; DOXORUBICIN; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METADHERIN; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; TAMOXIFEN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL PROLIFERATION; CYTOGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INFLAMMATION; METASTASIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84931275215     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. [1] Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
2. [2] Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ and Fisher PB. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Onco-gene 2002; 21: 3592-3602.
3. [3] Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ and Fisher PB. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005; 353: 8-15.
4. [4] Huang Y and Li LP. Progress of cancer research on astrocyte elevated gene-1/Metadherin (Review). Oncol Lett 2014; 8: 493-501.
5. [5] Brown DM and Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004; 5: 365-374.
6. [6] Britt DE, Yang DF, Yang DQ, Flanagan D, Callanan H, Lim YP, Lin SH and Hixson DC. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res 2004; 300: 134-148.
7. [7] Sutherland HG, Lam YW, Briers S, Lamond AI and Bickmore WA. 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp Cell Res 2004; 294: 94-105.
8. [8] Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K and Fisher PB. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 2006; 66: 1509-1516.
9. [9] Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC, Bruce JN, Volsky DJ and Fisher PB. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 2007; 114: 155-170.
10. [10] Thirkettle HJ, Girling J, Warren AY, Mills IG, Sahadevan K, Leung H, Hamdy F, Whitaker HC and Neal DE. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res 2009; 15: 3003-3013.
11. [11] Lee SG, Su ZZ, Emdad L, Sarkar D and Fisher PB. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006; 103: 17390-17395.
12. [12] Emdad L, Das SK, Dasgupta S, Hu B, Sarkar D and Fisher PB. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis. Adv Cancer Res 2013; 120: 75-111.
13. [13] Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF and Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008; 27: 1114-1121.
14. [14] Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M and Dahiya R. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007; 26: 7647-7655.
15. [15] Li J, Yang L, Song L, Xiong H, Wang L, Yan X, Yuan J, Wu J and Li M. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 2009; 28: 3188-3196.
16. [16] Ke ZF, Mao X, Zeng C, He S, Li S and Wang LT. AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis. Med Oncol 2013; 30: 383.
17. [17] Song L, Li W, Zhang H, Liao W, Dai T, Yu C, Ding X, Zhang L and Li J. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 2009; 219: 317-326.
18. [18] Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y, Hao M, Sheng S, Sun Y, Zhang H, Long J, Liang Y and Hu C. Astrocyte elevated gene-1 (AEG-1) shRNA sensitizes Huaier polysaccharide (HP)-induced anti-metastatic potency via inactivating downstream P13K/Akt pathway as well as augmenting cell-mediated immune response. Tumour Biol 2014; 35: 4219-4224.
19. [19] Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ and Fisher PB. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 2008; 68: 1478-1484.
20. [20] Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM, Fisher PB and Sarkar D. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009; 119: 465-477.
21. [21] Robertson CL, Srivastava J, Siddiq A, Gredler R, Emdad L, Rajasekaran D, Akiel M, Shen XN, Guo C, Giashuddin S, Wang XY, Ghosh S, Subler MA, Windle JJ, Fisher PB and Sarkar D. Genetic deletion of AEG-1 prevents hepatocarcinogenesis. Cancer Res 2014; 74: 6184-93.
22. [22] Alexia C, Poalas K, Carvalho G, Zemirli N, Dwyer J, Dubois SM, Hatchi EM, Cordeiro N, Smith SS, Castanier C, Le Guelte A, Wan L, Kang Y, Vazquez A, Gavard J, Arnoult D and Bidere N. The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor kappaB signaling. Sci Signal 2013; 6: ra79.
23. [23] Khuda, II, Koide N, Noman AS, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T and Yokochi T. Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology 2009; 128: e700-706.
24. [24] Zhao Y, Kong X, Li X, Yan S, Yuan C, Hu W and Yang Q. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 2011; 6: e29363.
25. [25] Jian-bo X, Hui W, Yu-long H, Chang-hua Z, Long-juan Z, Shi-rong C and Wen-hua Z. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol 2011; 28: 455-462.
26. [26] Zhang F, Yang Q, Meng F, Shi H, Li H, Liang Y and Han A. Astrocyte elevated gene-1 interacts with beta-catenin and increases migration and invasion of colorectal carcinoma. Mol Carcinog 2013; 52: 603-610.
27. [27] Ge X, Lv X, Feng L, Liu X, Gao J, Chen N and Wang X. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma. PLoS One 2012; 7: e39449.
28. [28] Kong X, Moran MS, Zhao Y and Yang Q. Inhibition of metadherin sensitizes breast cancer cells to AZD6244. Cancer Biol Ther 2012; 13: 43-49.
29. [29] Wei J, Li Z, Chen W, Ma C, Zhan F, Wu W and Peng Y. AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation. Cell Biol Int 2013; 37: 1016-1021.
30. [30] Yu C, Chen K, Zheng H, Guo X, Jia W, Li M, Zeng M, Li J and Song L. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009; 30: 894-901.
31. [31] Nikpour M, Emadi-Baygi M, Fischer U, Niegisch G, Schulz WA and Nikpour P. MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer. Urol Oncol 2014; 32: 670-677.
32. [32] Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK, Dash R, Yacoub A, Fuller CE, Shah K, Dent P, Bruce JN and Fisher PB. Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther 2010; 9: 79-88.
33. [33] Liu H, Song X, Liu C, Xie L, Wei L and Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 2009; 28: 19.
34. [34] Su P, Zhang Q and Yang Q. Immunohisto-chemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagn Pathol 2010; 5: 38.
35. [35] Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G and Yang Q. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene 2014; 33: 3119-3128.
36. [36] Carmeliet P and Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
37. [37] Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche H, Sarkar D and Fisher PB. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A 2009; 106: 21300-21305.
38. [38] Srivastava J, Siddiq A, Emdad L, Santhekadur PK, Chen D, Gredler R, Shen XN, Robertson CL, Dumur CI, Hylemon PB, Mukhopadhyay ND, Bhere D, Shah K, Ahmad R, Giashuddin S, Stafflinger J, Subler MA, Windle JJ, Fisher PB and Sarkar D. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model. Hepatology 2012; 56: 1782-1791.
39. [39] Li C, Li R, Song H, Wang D, Feng T, Yu X, Zhao Y, Liu J, Wang Y and Geng J. Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. J Surg Oncol 2011; 103: 184-192.
40. [40] Lee SG, Jeon HY, Su ZZ, Richards JE, Vozhilla N, Sarkar D, Van Maerken T and Fisher PB. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009; 28: 2476-2484.
41. [41] Sun S, Ke Z, Wang F, Li S, Chen W, Han A, Wang Z, Shi H, Wang LT and Chen X. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression. Hum Pathol 2012; 43: 1051-1060.
42. [42] Wang F, Ke ZF, Sun SJ, Chen WF, Yang SC, Li SH, Mao XP and Wang LT. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis. Cancer Biol Ther 2011; 12: 539-548.
43. [43] Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG and Kang Y. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009; 15: 9-20.
44. [44] Zhou Z, Deng H, Yan W, Huang H, Deng Y, Li Y and Tian D. Expression of metadherin/AEG-1 gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 353-357.
45. [45] Jiang T, Zhu A, Zhu Y and Piao D. Clinical implications of AEG-1 in liver metastasis of colorectal cancer. Med Oncol 2012; 29: 2858-2863.
46. [46] Liu DC and Yang ZL. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Diagn Cytopathol 2013; 41: 199-205.
47. [47] Chen W, Ke Z, Shi H, Yang S and Wang L. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 2010; 57: 522-529.
48. [48] Wan L, Hu G, Wei Y, Yuan M, Bronson RT, Yang Q, Siddiqui J, Pienta KJ and Kang Y. Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasis. Cancer Res 2014; 74: 5336-5347.
49. [49] Li C, Liu J, Lu R, Yu G, Wang X, Zhao Y, Song H, Lin P, Sun X, Yu X, Zhang Y, Ning X and Geng J. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Int J Gynecol Cancer 2011; 21: 602-608.
50. [50] Turley EA, Veiseh M, Radisky DC and Bissell MJ. Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 2008; 5: 280-290.
51. [51] Zeisberg M and Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437.
52. [52] Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C, Moran MS, Shao C and Yang Q. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci 2011; 102: 1151-1157.
53. [53] Ward A, Balwierz A, Zhang JD, Kublbeck M, Pawitan Y, Hielscher T, Wiemann S and Sahin O. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 2013; 32: 1173-1182.
54. [54] Liu K, Guo L, Miao L, Bao W, Yang J, Li X, Xi T and Zhao W. Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Anticancer Drugs 2013; 24: 494-503.
55. [55] Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J and Zhou J. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2011; 17: 7294-7302.
56. [56] Tang J, Shen L, Yang Q and Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif 2014; 47: 427-434.
57. [57] Yu C, Liu Y, Tan H, Li G, Su Z, Ren S, Zhu G, Tian Y, Qiu Y and Zhang X. Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition. Cancer Lett 2014; 343: 258-267.
58. [58] Sun W, Fan YZ, Xi H, Lu XS, Ye C and Zhang JT. Astrocyte elevated gene-1 overexpression in human primary gallbladder carcinomas: an unfavorable and independent prognostic factor. Oncol Rep 2011; 26: 1133-1142.
59. [59] Ke ZF, He S, Li S, Luo D, Feng C and Zhou W. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis. Cancer Epidemiol 2013; 37: 179-185.
60. [60] Zhou J, Li J, Wang Z, Yin C and Zhang W. Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival. Asia Pac J Clin Oncol 2012; 8: e42-48.
61. [61] Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS and Li M. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008; 14: 3319-3326.
62. [62] Tokunaga E, Nakashima Y, Yamashita N, Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M and Maehara Y. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer 2014; 21: 341-349.
63. [63] Li C, Chen K, Cai J, Shi QT, Li Y, Li L, Song H, Qiu H, Qin Y and Geng JS. Astrocyte elevated gene-1: a novel independent prognostic biomarker for metastatic ovarian tumors. Tumour Biol 2014; 35: 3079-3085.
64. [64] Song H, Li C, Lu R, Zhang Y and Geng J. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer 2010; 20: 1188-1196.
65. [65] Xia X, Du R, Zhao L, Sun W and Wang X. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis of oral squamous cell carcinoma. Hum Pathol 2014; 45: 858-865.
66. [66] Chen X, Dong K, Long M, Lin F, Wang X, Wei J, Ren J and Zhang H. Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors. Oncol Lett 2012; 4: 319-323.
67. [67] Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen D, Forcier T, Shah K, Saxena U, Hansen U, Fisher PB and Sarkar D. Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A 2009; 106: 12938-12943.
68. [68] Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J, Shah K, Fisher PB and Sarkar D. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res 2010; 70: 3249-3258.
69. [69] Qian BJ, Yan F, Li N, Liu QL, Lin YH, Liu CM, Luo YP, Guo F and Li HZ. MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer. Cancer Immunol Immunother 2011; 60: 883-893.
70. [70] Meng X, Brachova P, Yang S, Xiong Z, Zhang Y, Thiel KW and Leslie KK. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS One 2011; 6: e20920.
71. [71] Huang S, Wu B, Li D, Zhou W, Deng G, Zhang K and Li Y. Knockdown of astrocyte elevated gene-1 inhibits tumor growth and modifies microRNAs expression profiles in human colorectal cancer cells. Biochem Biophys Res Commun 2014; 444: 338-345.
72. [72] Yang Y, Wu J, Guan H, Cai J, Fang L, Li J and Li M. MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Lett 2012; 586: 3608-3612.
73. [73] Gong Z, Liu W, You N, Wang T, Wang X, Lu P, Zhao G, Yang P, Wang D and Dou K. Prognostic significance of metadherin overexpression in hepatitis B virus-related hepatocellular carcinoma. Oncol Rep 2012; 27: 2073-2079.
74. [74] Ahn S, Hyeon J and Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy. Gut Liver 2013; 7: 206-212.
75. [75] Baygi ME and Nikpour P. Deregulation of MTDH gene expression in gastric cancer. Asian Pac J Cancer Prev 2012; 13: 2833-2836.
76. [76] Zhang CF, Xia YH, Zheng QF, Li ZJ, Guo XH, Zhou HC, Zhang LL, Dong LP, Han Y, Liu ZE, Wang WJ and Luo YL. [Effect of silencing AEG-1 with small interfering RNA on the proliferation and cell cycle of gastric carcinoma SGC-7901 cells]. Zhonghua Zhong Liu Za Zhi 2013; 35: 22-27.
77. [77] Huang W, Yang L, Liang S, Liu D, Chen X, Ma Z, Zhai S, Li P and Wang X. AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers. Dig Dis Sci 2013; 58: 2873-2880.
78. [78] Song H, Li C, Li R and Geng J. Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis 2010; 25: 1201-1209.
79. [79] Gnosa S, Shen YM, Wang CJ, Zhang H, Stratmann J, Arbman G and Sun XF. Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines. J Transl Med 2012; 10: 109.
80. [80] Wang N, Du X, Zang L, Song N, Yang T, Dong R, Wu T, He X and Lu J. Prognostic impact of Metadherin-SND1 interaction in colon cancer. Mol Biol Rep 2012; 39: 10497-10504.
81. [81] Casimiro S, Fernandes A, Oliveira AG, Franco M, Pires R, Peres M, Matias M, Tato-Costa J, Guerra N, Ramos M, Cruz J and Costa L. Metadherin expression and lung relapse in patients with colorectal carcinoma. Clin Exp Metastasis 2014; 31: 689-696.
82. [82] Liao WT, Guo L, Zhong Y, Wu YH, Li J and Song LB. Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. J Transl Med 2011; 9: 205.
83. [83] Erdem H, Oktay M, Yildirim U, Uzunlar AK and Kayikci MA. Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: a microarray study. Pol J Pathol 2013; 64: 28-32.
84. [84] Xu C, Kong X, Wang H, Zhang N, Ding X, Li X and Yang Q. MTDH mediates estrogen-independent growth and tamoxifen resistance by down-regulating PTEN in MCF-7 breast cancer cells. Cell Physiol Biochem 2014; 33: 1557-1567.
85. [85] Wan L, Lu X, Yuan S, Wei Y, Guo F, Shen M, Yuan M, Chakrabarti R, Hua Y, Smith HA, Blanco MA, Chekmareva M, Wu H, Bronson RT, Haffty BG, Xing Y and Kang Y. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell 2014; 26: 92-105.
86. [86] Meng F, Luo C, Ma L, Hu Y and Lou G. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. Int J Gynecol Pathol 2011; 30: 145-150.
87. [87] Li C, Li Y, Wang X, Wang Z, Cai J, Wang L, Zhao Y, Song H, Meng X, Ning X, Xu C, Lin M, Li L and Geng J. Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma. Histopathology 2012; 60: 953-963.
88. [88] Yuan C, Li X, Yan S, Yang Q, Liu X and Kong B. The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility. PLoS One 2012; 7: e51561.
89. [89] Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, Song L, Yuan J, Li J and Li M. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 2010; 70: 3750-3759.
90. [90] Xia Z, Zhang N, Jin H, Yu Z, Xu G and Huang Z. Clinical significance of astrocyte elevated gene-1 expression in human oligodendrogliomas. Clin Neurol Neurosurg 2010; 112: 413-419.
91. [91] Liu HY, Liu CX, Han B, Zhang XY and Sun RP. AEG-1 is associated with clinical outcome in neuroblastoma patients. Cancer Biomark 2012; 11: 115-121.
92. [92] Yao Y, Gu X, Liu H, Wu G, Yuan D, Yang X and Song Y. Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br J Cancer 2014; 111: 355-364.
93. [93] Liu B, Wu Y and Peng D. Astrocyte elevated gene-1 regulates osteosarcoma cell invasion and chemoresistance via endothelin-1/endothelin A receptor signaling. Oncol Lett 2013; 5: 505-510.
94. [94] Yan J, Zhang M, Chen Q and Zhang X. Expression of AEG-1 in human T-cell lymphoma enhances the risk of progression. Oncol Rep 2012; 28: 2107-2114.
95. [95] Li PP, Feng LL, Chen N, Lu K, Meng XH, Ge XL, Lv X and Wang X. Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma. Int J Clin Exp Med 2014; 7: 2081-2086.
96. [96] Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H, Enokida H, Nakagawa M, Okamoto Y and Seki N. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 2011; 56: 595-601.
97. [97] Wang YP, Liu IJ, Chiang CP and Wu HC. Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1. Mol Cancer 2013; 12: 109.